SCHEMBL27645234

SCHEMBL27645234

[O]C(=O)Nc1cc(OC(F)(F)F)cc(OC(F)(F)F)c1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 4/20 0.50
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ MAPT P10636 3/20 0.42
▸ TRPV1 Q8NER1 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ HTT P42858 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ P2RX1 P51575 1/20 0.40
▸ FAAH O00519 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2095973 0.82 ALDH1A1 (0.60) EPHX2NPC1RAB9AMAPTHTT
SCHEMBL2091276 0.81 EPHX2 (0.47) EPHX2NPC1RAB9ATRPV1KMT2A
SCHEMBL2096310 0.81 EPHX2 (0.76) EPHX2NPC1RAB9AMAPTTRPV1
SCHEMBL23213602 0.75 EPHX2 (0.45) EPHX2NPC1RAB9AMAPTTRPV1
SCHEMBL3173854 0.74 HDAC3 (0.41) EPHX2NPC1RAB9AMAPT
SCHEMBL29556169 0.74 EPHX2 (0.56) EPHX2NPC1RAB9AMAPTKMT2A
SCHEMBL30104928 0.74 ALDH1A1 (0.49) EPHX2NPC1RAB9AMAPTKMT2A
SCHEMBL20357431 0.72 FFAR4 (0.43) EPHX2MAPTKMT2AHTTALDH1A1
SCHEMBL2094856 0.71 MAPT (0.38) EPHX2NPC1RAB9AMAPT
SCHEMBL2091142 0.71 L3MBTL1 (0.42) EPHX2NPC1RAB9AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100497345-C 2, 3-dihydro-6-nitroimidazolo [2,1-b] oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2009-06-10 — — CN disclosed
CN-1878777-A 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2006-12-13 — — CN disclosed
Send feedback